⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

LIMN News

Liminatus Pharma, Inc. Class A Common Stock

Liminatus Pharma, Inc. (NASDAQ: LIMN) Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation